Scan to Download
One power score. Smarter investment decisions
Bright Minds Biosciences Inc
DRUG50.145USD
+5.465+12.23%
Close 09/18, 16:00（ET）Quotes delayed by 15 min
43.810USD+43.810After-hours 09/19, 20:00 (ET)
355.26MMarket Cap
LossP/E TTM
Bright Minds Biosciences Inc
50.145
+5.465+12.23%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q3
FY2020Q2
FY2020Q1
Operating expenses
1493.23%3.29M
500.52%3.34M
-4.59%1.62M
-50.15%788.70K
-116.35%-235.98K
-72.86%555.94K
-26.01%1.70M
-47.42%1.58M
-45.78%1.44M
-54.24%2.05M
-52.48%2.29M
1.43%3.01M
-27.00%2.66M
187.69%4.48M
660.36%4.82M
--2.97M
--3.65M
--1.56M
--634.43K
----
----
----
----
R&D expenses
625.26%2.69M
498.20%2.56M
-14.70%1.05M
-61.88%416.06K
-64.67%371.16K
-69.36%428.47K
-16.04%1.23M
-57.06%1.09M
-48.78%1.05M
-62.65%1.40M
-62.04%1.46M
15.08%2.54M
-24.25%2.05M
295.54%3.74M
1311.24%3.85M
--2.21M
--2.71M
--946.35K
--272.47K
----
----
----
----
Depreciation, depletion, and amortization
-12.52%15.85K
24.27%22.51K
18.88%21.53K
5.01%19.02K
0.00%18.11K
-0.01%18.11K
0.01%18.11K
200.02%18.11K
--18.11K
--18.11K
--18.11K
--6.04K
----
----
----
----
----
----
----
----
----
----
----
Other operating expenses
----
----
----
----
---937.90K
---323.29K
----
----
----
----
----
--0.00
--0.00
-100.00%0.00
-100.00%0.00
--0.00
--0.00
--1.46K
--17.21K
----
----
----
----
Operating profit
-1493.23%-3.29M
-500.52%-3.34M
4.59%-1.62M
50.15%-788.70K
116.35%235.98K
72.86%-555.94K
26.01%-1.70M
47.42%-1.58M
45.78%-1.44M
54.24%-2.05M
52.48%-2.29M
-1.43%-3.01M
27.00%-2.66M
-187.69%-4.48M
-660.36%-4.82M
---2.97M
---3.65M
---1.56M
---634.43K
----
----
----
----
Net non-operating interest income (expenses)
Non-operating interest income
3077.63%476.23K
--509.38K
--4.32K
--6.01K
--14.99K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Non-operating interest expense
586.38%8.52K
538.76%13.58K
117.33%6.46K
-31.14%2.61K
-72.88%1.24K
-60.14%2.13K
-50.93%2.97K
74.23%3.79K
--4.58K
--5.33K
--6.05K
--2.17K
----
----
----
----
----
----
----
----
----
----
----
Gains from sale of securities
-13421.44%-2.68M
-569.72%-107.69K
11236.25%1.67M
-79.52%11.86K
-96.18%-19.83K
-560.06%-16.08K
139.67%14.73K
11.05%57.93K
-336.51%-10.11K
134.24%3.50K
-8.94%-37.13K
-47.64%52.17K
-96.25%4.27K
62.15%-10.21K
-4.47%-34.09K
--99.63K
--114.06K
---26.96K
---32.63K
----
----
----
----
Special income (expenses)
----
----
----
--0.00
----
----
----
100.00%0.00
----
----
----
---2.00K
----
----
----
----
----
----
----
----
----
----
----
Other non-operating income (expenses)
--257.87K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Income before tax
-2380.51%-5.24M
-413.88%-2.95M
102.95%49.61K
49.38%-773.44K
115.77%229.90K
72.00%-574.14K
27.88%-1.68M
48.40%-1.53M
45.14%-1.46M
54.31%-2.05M
51.93%-2.34M
-3.28%-2.96M
24.77%-2.66M
-183.43%-4.49M
-628.28%-4.86M
---2.87M
---3.53M
---1.58M
---667.06K
----
----
----
----
Income after tax
-2380.51%-5.24M
-413.88%-2.95M
102.95%49.61K
49.38%-773.44K
115.77%229.90K
72.00%-574.14K
27.88%-1.68M
48.40%-1.53M
45.14%-1.46M
54.31%-2.05M
51.93%-2.34M
-3.28%-2.96M
24.77%-2.66M
-183.43%-4.49M
-628.28%-4.86M
---2.87M
---3.53M
---1.58M
---667.06K
----
----
----
----
Net income from continuous operations
-2380.51%-5.24M
-413.88%-2.95M
102.95%49.61K
49.38%-773.44K
115.77%229.90K
72.00%-574.14K
27.88%-1.68M
48.40%-1.53M
45.14%-1.46M
54.31%-2.05M
51.93%-2.34M
-3.28%-2.96M
24.77%-2.66M
-183.43%-4.49M
-628.28%-4.86M
-657.62%-2.87M
-6465.09%-3.53M
-25677.87%-1.58M
-1488.42%-667.06K
---378.42K
---53.82K
---6.14K
---41.99K
Net income attributable to controlling interests
-2392.25%-3.85M
-383.52%-2.05M
102.71%34.50K
49.18%-571.90K
115.26%168.09K
72.05%-424.13K
26.23%-1.27M
47.45%-1.13M
46.65%-1.10M
57.74%-1.52M
55.17%-1.72M
5.30%-2.14M
27.56%-2.07M
-184.77%-3.59M
-633.81%-3.85M
-695.92%-2.26M
-7089.61%-2.85M
-28758.98%-1.26M
-1520.36%-524.00K
---284.12K
---39.65K
---4.37K
---32.34K
Net income attributable to common shareholders
-2392.25%-3.85M
-383.52%-2.05M
102.71%34.50K
49.18%-571.90K
115.26%168.09K
72.05%-424.13K
26.23%-1.27M
47.45%-1.13M
46.65%-1.10M
57.74%-1.52M
55.17%-1.72M
5.30%-2.14M
27.56%-2.07M
-184.77%-3.59M
-633.81%-3.85M
-695.92%-2.26M
-7089.61%-2.85M
-28758.98%-1.26M
-1520.36%-524.00K
---284.12K
---39.65K
---4.37K
---32.34K
Basic earnings per share
-1537.13%-0.74
-225.91%-0.42
101.84%0.01
57.33%-0.17
102.66%0.05
76.24%-0.13
32.68%-0.44
62.09%-0.41
-72.51%-1.93
71.41%-0.54
68.26%-0.65
11.54%-1.07
28.19%-1.12
-65.76%-1.89
-256.01%-2.05
-308.71%-1.21
-3610.70%-1.56
-23704.17%-1.14
-1656.71%-0.58
---0.30
---0.04
--0.00
---0.03
Diluted earnings per share
-1596.70%-0.74
-225.91%-0.42
101.84%0.01
57.33%-0.17
102.56%0.05
76.24%-0.13
32.68%-0.44
62.09%-0.41
-72.51%-1.93
71.41%-0.54
68.26%-0.65
11.54%-1.07
28.19%-1.12
-65.76%-1.89
-256.01%-2.05
-308.71%-1.21
-3610.70%-1.56
-23704.17%-1.14
-1656.71%-0.58
---0.30
---0.04
--0.00
---0.03
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
----
----
----
----
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
